AI-generated summary
The authors studied a 650 nm low-level laser applied at four energy doses to mice with dinitrochlorobenzene-induced atopic dermatitis-like skin disease. They report that irradiated mice had lower serum IgE, IL-6 and TNF-α levels, reduced epidermal thickness and fewer mast cells than untreated mice, and that IL-4 was lowered in all but the highest-dose group. The authors suggest the laser may alleviate symptoms, but this is an animal study.
- Who or what was studied
- BALB/c mice with dinitrochlorobenzene-induced atopic dermatitis-like disease
- Wavelengths
- 650 nm
- Limits stated in the abstract
- The study was conducted in mice, so results may not apply to humans.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on spandidos-publications.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 650 nm
- Energy density (fluence)
- 2 J/cm2, 4 J/cm2, 6 J/cm2, 8 J/cm2
- Power
- 50 mW
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Laser, Randomized controlled trial, Control group, Wavelength. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.